You are here: Industry Insights > Products Guide > Urgent Sourcing Needs of【En-CPhI.cn】2018.11.05

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

Riociguat(625115-55-1)

Methyl [4,6-diaMino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyriMidin-5-yl]carbaMate

2-[1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyriMidine-4,5,6-triaMine(428854-24-4)

4,6-PyriMidinediaMine, 2-[1-[(2-fluorophenyl)Methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-(phenylazo)-

1H-Pyrazolo[3,4-b]pyridine-3-carboximidamide, 1-[(2-fluorophenyl)methyl]-, hydrochloride (1:1)

1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide(256376-68-8)

Urgent Sourcing Needs of【En-CPhI.cn】2018.11.05

en-cphi.cnNovember 05, 2018

Tag: en-CPhI.cn , sourcing need , urgent

Favorites

【En-CPhI.cn】provides the free-of-charge One-to-One Matching Service every week. Your dedicated client service officer collects your sourcing needs and searches suitable suppliers for you to improve your sourcing efficiency greatly.

The validity of the sourcing needs lasts one week.

If your company could provide the following api active product ingredient and other products, you can email the product name to Freya. She will reply you with the detailed information including the buyers' contact information.

Contact Person: Freya.Yao

Email: Freya.Yao@ubmsinoexpo.com

Tel: 86-21-33392401

ID	Name of the Product	CAS No.	Quantity	Detailed Information	Country
1	19-Norkaur-16-en-18-oicacid, 2,15-dihydroxy-, (2b,4a,15a)-	10391-47-6	0.5 or 1.0g	Quantity:0.5 or 1.0gQuality Standards: chemistry purityPacking:Place of Origin:Purity:Standard:Detailed Description:	China (Mainland)

Previous:Bioasis Announces xB3 ™ Platform Technology Licensing Agreement with Prothena

Next:Plasticell receives EU funding to advance neurodegenerative disease research

Research and Application of Artemisia Argyi

XiaonishaAugust 12, 2024

Mugwort, also known as fragrant mugwort or Artemisia argyi, is a herbaceous plant belonging to the Compositae family.

Research Progress on the Application of Biologics in Pediatric Asthma

XiaomichongJuly 19, 2024

Research Progress on the Pharmacological Effects and New Drug Forms of Artemisinin and Its Derivatives

XiaomichongJuly 19, 2024

Urgent Sourcing Needs of【En-CPhI.cn】2018.11.05 | Pharmasources.com

Research and Development Status and Progress of Antibody Technology (Part Ⅱ)

XiaomichongJuly 18, 2024

Antibody-based biological therapeutic drugs have been playing an increasingly important role in biopharmaceuticals due to their strong targeting, good specificity, and significant therapeutic effects.

Urgent Sourcing Needs of【En-CPhI.cn】2018.11.05

Related News

Research and Application of Artemisia Argyi

Research Progress on the Application of Biologics in Pediatric Asthma

Research Progress on the Pharmacological Effects and New Drug Forms of Artemisinin and Its Derivatives

Research and Development Status and Progress of Antibody Technology (Part Ⅱ)

You may like
More>>

Urgent Sourcing Needs of【En-CPhI.cn】2018.11.05

Related News

Research and Application of Artemisia Argyi

Research Progress on the Application of Biologics in Pediatric Asthma

Research Progress on the Pharmacological Effects and New Drug Forms of Artemisinin and Its Derivatives

Research and Development Status and Progress of Antibody Technology (Part Ⅱ)

You may likeMore>>

You may like
More>>